Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fernandez del Moral

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Tandheelkunde|April 1, 1992
[Prostate cancer]P Fernandez del Moral, W P Witjes
Progress in Clinical and Biological Research|January 1, 1988
LHRH-analogues therapy for metastatic prostate cancerF M Debruyne, P Fernandez del Moral, A D Geboers
Urology|May 1, 1989
Ketoconazole high dose in management of hormonally pretreated patients with progressive metastatic prostate cancer. Dutch South-Eastern Urological Cooperative GroupF J Witjes, F M Debruyne, P Fernandez del Moral, et al.
European Urology|January 1, 1995
Improved subjective responses to orchiectomy plus nilutamide (anandron) in comparison to orchiectomy plus placebo in metastatic prostate cancer. International Anandron Study GroupG A Dijkman, P Fernandez del Moral, F M Debruyne, et al.
Urology|August 1, 1988
Can combined DES and LHRH depot therapy (ICI 118630) prevent endocrinologic and clinical flare-up in metastatic prostate cancer?P Fernandez del Moral, T T Litjens, E H Weil, et al.
Urology|December 1, 1996
Three-month depot of goserelin acetate: clinical efficacy and endocrine profile. Dutch South East Cooperative Urological GroupP Fernandez del Moral, G A Dijkman, F M Debruyne, et al.
Cancer|June 15, 1990
Analysis of prognostic factors in disseminated prostatic cancer. An update. Dutch Southeastern Urological Cooperative GroupP F Mulders, G A Dijkman, P Fernandez del Moral, et al.
The Prostate|September 19, 1997
Liarozole (R75251) in hormone-resistant prostate cancer patientsG A Dijkman, P Fernandez del Moral, J Bruynseels, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 26, 1986
[Treatment of advanced prostate carcinoma with a depot form of an LH-RH analog: preliminary endocrinological and clinical results]T T Litjens, P Fernandez del Moral, J P van Laarhoven, et al.
European Urology|January 1, 1992
Value of biochemical markers in the management of disseminated prostatic cancerP F Mulders, P Fernandez del Moral, A G Theeuwes, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Tandheelkunde|April 1, 1992
[Prostate cancer]P Fernandez del Moral, W P Witjes
Progress in Clinical and Biological Research|January 1, 1988
LHRH-analogues therapy for metastatic prostate cancerF M Debruyne, P Fernandez del Moral, A D Geboers
Urology|May 1, 1989
Ketoconazole high dose in management of hormonally pretreated patients with progressive metastatic prostate cancer. Dutch South-Eastern Urological Cooperative GroupF J Witjes, F M Debruyne, P Fernandez del Moral, et al.
European Urology|January 1, 1995
Improved subjective responses to orchiectomy plus nilutamide (anandron) in comparison to orchiectomy plus placebo in metastatic prostate cancer. International Anandron Study GroupG A Dijkman, P Fernandez del Moral, F M Debruyne, et al.
Urology|August 1, 1988
Can combined DES and LHRH depot therapy (ICI 118630) prevent endocrinologic and clinical flare-up in metastatic prostate cancer?P Fernandez del Moral, T T Litjens, E H Weil, et al.
Urology|December 1, 1996
Three-month depot of goserelin acetate: clinical efficacy and endocrine profile. Dutch South East Cooperative Urological GroupP Fernandez del Moral, G A Dijkman, F M Debruyne, et al.
Cancer|June 15, 1990
Analysis of prognostic factors in disseminated prostatic cancer. An update. Dutch Southeastern Urological Cooperative GroupP F Mulders, G A Dijkman, P Fernandez del Moral, et al.
The Prostate|September 19, 1997
Liarozole (R75251) in hormone-resistant prostate cancer patientsG A Dijkman, P Fernandez del Moral, J Bruynseels, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 26, 1986
[Treatment of advanced prostate carcinoma with a depot form of an LH-RH analog: preliminary endocrinological and clinical results]T T Litjens, P Fernandez del Moral, J P van Laarhoven, et al.
European Urology|January 1, 1992
Value of biochemical markers in the management of disseminated prostatic cancerP F Mulders, P Fernandez del Moral, A G Theeuwes, et al.
Pageof 2